Suven Life Sciences jumps on securing 7 product patents

The company has secured 7 product patents across SE Asia and Europe

Shares of Suven Life Sciences were up over 4% at Rs 267 after the company said it has received seven product patents for their new chemical entities in several countries.

Suven Life Sciences has secured patents in ARIPO ( AP 3340), Europe (2611444), Hong Kong (HK 1187613), Japan (5805795), Macau (J/001756 & J/001848) and South Korea (10-1554407) for new chemicals entities for CNS therapy and these patents are valid until 2031, the company said in a release.

The selective H3 ligands discovered by Suven are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders.

The stock opended at Rs 255 and touched a high of Rs 273. At 12:50pm, over 1.4 million shares were traded on both the stock exchanges.